Standex International ((SXI)) has held its Q3 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Standex International’s latest earnings call struck an upbeat tone, with management emphasizing broad-based revenue growth, record results in Electronics, and powerful momentum in Aerospace & Defense. Investments are pressuring some margins in the near term, but rising earnings, stronger cash generation, and a leaner balance sheet suggest the company is building a sturdier platform for long-term expansion.
Top-Line Growth Reaccelerates
Standex reported total sales of $224.6 million, up 8.1% from a year earlier, with 6.5% of that increase coming organically. Management highlighted that growth was not only volume-driven but also supported by healthy pricing and mix, underscoring resilient customer demand across key end markets.
Record Electronics Performance
Electronics delivered record revenue of $119.7 million, a 7.6% year-on-year gain including 6.8% organic growth. A book-to-bill ratio of 1.14 and two straight months with orders above $50 million signal sustained demand and provide good visibility for continued strength in coming quarters.
Aerospace & Defense Rebranded and Accelerating
The former Engineering Technologies segment has been repositioned as Standex Aerospace & Defense, reflecting its growing strategic importance. Revenue surged 33.7% to $36.6 million, with 20.8% organic growth and the remainder from the McStarlite acquisition, helped by robust project activity in commercializing space applications.
New Product Engine Driving Growth
New product sales jumped about 40% to roughly $18.7 million in the quarter, highlighting successful innovation and commercialization efforts. Management expects pro forma new product sales to climb by $24 million to $64 million in fiscal 2026, which should contribute around 300 basis points to organic growth.
Shift Toward Fast-Growth End Markets
Sales into fast-growth end markets reached approximately $69 million, or about 30% of total company revenue this quarter. Standex expects sales into these higher-velocity niches to total roughly $270 million for the full year, maintaining a 30% mix and supporting a more durable growth profile.
Margins and EPS Edge Higher
Consolidated adjusted operating margin expanded by 30 basis points from a year earlier to 19.7%, despite heavier growth investments. Adjusted earnings per share climbed 13.5% to $2.21, reflecting operating leverage from higher volumes and disciplined cost control.
Balance Sheet Fortified by Divestiture
Standex completed the divestiture of Federal Industries at an enterprise value of about $70 million and used the proceeds to pay down roughly $62 million of debt. Net debt fell to $369.1 million, net leverage eased to 1.9 times, and the company ended the period with about $191 million of liquidity and $103.7 million in cash.
Free Cash Flow Trending Up
Free cash flow improved to $6.3 million in the fiscal third quarter, up from $3.5 million a year earlier, on operating cash flow of $9.0 million. While working capital and growth investments still absorb cash, the underlying trend points to better cash conversion as volumes rise.
Dividend and M&A Firepower
The board declared the 247th consecutive quarterly cash dividend of $0.34 per share, an increase of about 6.3% from last year, underscoring confidence in cash generation. With leverage below 2 times and an active acquisition pipeline, management signaled continued appetite for bolt-on deals to accelerate growth.
Portfolio Simplification and Strategic Focus
Standex has reorganized into four segments—Electronics, Aerospace & Defense, Scientific, and Engraving & Hydraulics—to enhance transparency and focus. This shift supports the ongoing strategy to emphasize higher-growth, higher-margin engineered solutions while pruning non-core or lower-return assets.
Growth Investments Pinch Segment Margins
Electronics adjusted operating margin slipped 50 basis points to 29.3%, and Aerospace & Defense margin declined 60 basis points to 18%. Management attributed the modest compression to deliberate growth investments and a changing project mix, framing these pressures as temporary and aimed at future scale.
Scientific Feels Impact of NIH Cuts
Scientific segment revenue edged down 1.7% to $18.0 million as academic and research customers pulled back amid funding pressures tied to NIH cutbacks. Adjusted operating margin dipped 70 basis points to 21.9%, though management indicated the business remains structurally attractive despite these cyclical headwinds.
Engraving & Hydraulics Soft on Organic Basis
Engraving & Hydraulics posted revenue of $44.8 million, up 2.2% overall due to a 4% foreign exchange tailwind, but organic sales declined 1.8%. Weakness in hydraulic cylinder markets weighed on growth, partially offsetting strength elsewhere in the portfolio.
Near-Term Margin Outlook and Cost Headwinds
Management cautioned that adjusted operating margin in fiscal fourth quarter is likely to be slightly lower year-on-year, despite sequential improvement. Higher medical costs, increased variable compensation, and spending on capacity expansions are expected to more than offset underlying productivity gains in the short run.
Flat Operating Cash Flow and Rising CapEx
Net cash provided by operating activities was $9.0 million, essentially flat versus $9.6 million in the prior-year period as working capital needs rose with growth. Capital expenditures are slated to increase to $27–$30 million in fiscal 2026, reflecting stepped-up investments in capacity and capability that will temporarily lift cash outflows.
Exposure to Government Procurement Cycles
Standex flagged that significant upside in certain missile and defense programs hinges on the timing and scale of government procurement decisions. While management sees attractive long-term opportunities, ramp profiles remain uncertain and depend on the pace of multiyear commitments from government customers.
Debt Load Still Meaningful
Even after recent deleveraging, long-term debt stands at about $472.8 million, leaving the company with a substantial absolute obligation. Interest expense is expected to run between $6.8 million and $7.0 million in fiscal fourth quarter, keeping financing costs a notable factor in overall earnings.
Guidance and Forward-Looking Outlook
For fiscal fourth quarter 2026, Standex expects revenue to be slightly to moderately higher both sequentially and year-on-year, powered by mid- to high-single-digit organic growth, fast-growth market backlog, and rising new-product sales. For the full year, management still targets roughly $100 million of revenue growth versus 2025 with margin expansion, more than 15 new product launches, about $64 million in new-product sales, and around $270 million of sales into fast-growth markets, alongside elevated capex and interest costs.
Standex’s earnings call painted a picture of a company trading near-term margin and cash flow comfort for stronger long-term growth in targeted markets. With solid organic momentum, robust new-product traction, and a leaner portfolio backed by a healthier balance sheet, the overall tone was constructive, though investors will watch execution on capex, defense ramp timing, and the path to further deleveraging.